Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer\'s disease and major depressive disorder
AIFeb 13, 2025PRINCETON,N.J.,Feb. 12,2025-- OnCusp Therapeutics,Inc.,a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for
AIFeb 13, 2025Introducing the newly-built,gold-standard,solar-poweredD\'Marquee,primed to host more large-scaled events.
AIFeb 13, 2025NewOpenTable research shows 40% of Australians plan to dine out this Valentine\'s Day with 72% of coupled-up Aussies planning to enjoy a dinner date[1]
AIFeb 13, 2025Expands portfolio with seven new energy-efficient and high-performing Massive MIMO and Remote radios,Indoor 5G solutions,and new open fronthaul products called RAN Connect
AIFeb 13, 2025
English Morning News: Your Source for Regional News and Corporate
© English Morning News
Privacy Policy